Viewing Study NCT03242603

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2025-12-30 @ 6:04 AM
Study NCT ID: NCT03242603
Status: UNKNOWN
Last Update Posted: 2018-03-30
First Post: 2017-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells
Sponsor: National University Hospital, Singapore
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroblastoma Recurrent View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed, Refractory, Neuroblastoma View
None Anti-GD2 View
None Natural Killer (NK) Cells View
None Immunotherapy View